4 hrs ago
Bristol Myers Squibb Co. Announces Quarterly Dividend of $0.35
Bristol Myers Squibb announced a quarterly dividend on Wednesday, June 19th, ARN reports.
8 hrs ago
Customer Interaction Solutions
Bristol-Myers Squibb Names Dinesh C. Paliwal to Board of Directors
Bristol-Myers Squibb Company today announced that its Board of Directors has elected Dinesh C. Paliwal to the Board, effective July 1, 2013.
Tue Jun 18, 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for...
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza A )-- Bristol-Myers Squibb Company and AstraZeneca today announced top line results of the Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza A .
Mon Jun 17, 2013
Simcere Ties Up with Bristol-Myers - Analyst Blog
Simcere Pharmaceutical Group recently announced that it has entered into a strategic agreement with Bristol-Myers Squibb Company .
BMS, AbbVie: PFS in Phase II Elotuzumab Study
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone in Previously-Treated Multiple Myeloma a Median progression-free survival of 33 months reached after longer-term follow up in patients treated with elotuzumab 10 ... (more)
The News Journal
As the world of big drug companies streamlines operations by shrinking research-and-development staffs and outsourcing tasks amid patent losses on key medicines, the benefit is two-fold for specialty firms contracted to take on the work.
Sun Jun 16, 2013
China Biotech In Review: Mindray Medical Buys U.S. Ultrasound Company
Mindray Medical of Shenzhen will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound machine maker .
Sat Jun 15, 2013
Customer Interaction Solutions
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival...
Bristol-Myers Squibb Company and AbbVie today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses of the investigational monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone.
Fri Jun 14, 2013
TBWA\WorldHealth, April 2013
Founded in 2002, TBWA\WorldHealth is a healthcare marketing services network that combines medical expertise with a consumer-marketing heritage and a unique approach to solving client problems and driving growth through the proprietary strategies of Disruption and Media Arts.
Contract Pharma Breaking News
BMS, Simcere To Co-develop Orencia SC in China
Bristol-Myers Squibb and Simcere Pharmaceutical Group have expanded their strategic partnership to collaborate on the development and commercialization of the subcutaneous formulation of BMS's rheumatoid arthritis drug Orencia in China.
Thu Jun 13, 2013
Bristol Myers Squibb Given New $48.00 Price Target at Ubs Ag
The firm currently has a buy rating on the stock. A number of other firms have also recently commented on BMY.
Wed Jun 12, 2013
Bloomsbury Publishing Selects Alteva's UCaaS Solution
Bloomsbury Publishing, Inc., a general interest publisher of adult and children's books and U.S-based subsidiary of Bloomsbury Publishing Plc, has selected UCaaS solution for its new office space in Manhattan.
Warning: This Might Be The Most Overvalued Sector In The Market
When it comes to assessing the outlook for drugmakers, investors really only care about the pipeline of new drugs.
Wall St. Cheat Sheet
Cramer: Buy Bristol-Myers, General Mills, CVR Refining, But Sell These 2 Stocks
Bristol-Myers Squibb : Jim Cramer ranked this stock a Buy . Cramer previously ranked this stock a Buy on May 20, 2013.
Tue Jun 11, 2013
Bristol Myers Squibb PT Raised to $48.00
UBS AG's price target indicates a potential upside of 1.50% from the stock's previous close.
Mon Jun 10, 2013
Warning: The Rebound May Be Over For Big Pharma
As investors were picking up the pieces after the dot-com implosion, they came across another troubled sector.
Sales Operations Assistant, Americas
Position Profile Working closely with sales operations manager to ensure accurate and timely flow of title metadata to distributor systems; support of sales operations and sales departments.
Asbury Park Press
Ex-Bristol-Myers exec from East Brunswick admits to insider trading
Federal prosecutors say a former Bristol-Myers Squibb executive has admitted using his high-level position and access to nonpublic information to make about $310,000 from illegal insider trades.
Organovo Appoints Tamar D. Howson to Board of Directors
Organovo Holdings, Inc. , a biotechnology company focused on delivering breakthrough three-dimensional bioprinting technology, today announced that Tamar D. Howson has been appointed to the Company's Board of Directors.
Sat Jun 08, 2013
Top-Performing Dividend Payers in Health Care with the Most Upside Potential
It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb.